Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Everett

Showing results (291-300 of 361) with videos related to

Pageof 37
Sort By:
Annals of Internal Medicine|September 27, 2021
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular DiseaseElisabetta Patorno, Phyo T Htoo, Robert J Glynn, et al.
Ophthalmology|August 31, 2000
Screening for amblyopia in preverbal children with photoscreening photographs. III. improved grading criteria for hyperopiaP Y Tong, J P Macke, R E Bassin, et al.
American Journal of Hypertension|May 29, 2016
Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among WomenMonik C Jiménez, Kathryn M Rexrode, Gregory Kotler, et al.
Annals of Internal Medicine|January 17, 2022
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular DiseaseElisabetta Patorno, Phyo T Htoo, Robert J Glynn, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2010
Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experienceM B Sprakes, A C Ford, N C Suares, et al.
Annals of Internal Medicine|November 21, 2018
Intermediate Diabetes Outcomes in Patients Managed by Physicians, Nurse Practitioners, or Physician Assistants: A Cohort StudyGeorge L Jackson, Valerie A Smith, David Edelman, et al.
Experimental Hematology|June 1, 1989
Tissue iron deposition in untransfused beta-thalassemic miceL M Garrick, L A Strano-Paul, J E Hoke, et al.
Family Medicine|October 15, 2016
Dr Carek's Commentary on Training PAs and NPsChristine M Everett, Viviana Martinez-Bianchi, Perri Morgan, et al.
American Heart Journal|September 23, 2022
Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical careRishi J Desai, Robert J Glynn, Brendan M Everett, et al.
Diabetes Care|March 4, 2026
Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial EmulationsJohn W Ostrominski, Janinne Ortega-Montiel, Deborah J Wexler, et al.
Pageof 37

Showing results (291-300 of 361) with videos related to

Sort By:
Pageof 37
Annals of Internal Medicine|September 27, 2021
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular DiseaseElisabetta Patorno, Phyo T Htoo, Robert J Glynn, et al.
Ophthalmology|August 31, 2000
Screening for amblyopia in preverbal children with photoscreening photographs. III. improved grading criteria for hyperopiaP Y Tong, J P Macke, R E Bassin, et al.
American Journal of Hypertension|May 29, 2016
Association Between Markers of Inflammation and Total Stroke by Hypertensive Status Among WomenMonik C Jiménez, Kathryn M Rexrode, Gregory Kotler, et al.
Annals of Internal Medicine|January 17, 2022
Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular DiseaseElisabetta Patorno, Phyo T Htoo, Robert J Glynn, et al.
Alimentary Pharmacology & Therapeutics|November 6, 2010
Costs of care for Crohn's disease following the introduction of infliximab: a single-centre UK experienceM B Sprakes, A C Ford, N C Suares, et al.
Annals of Internal Medicine|November 21, 2018
Intermediate Diabetes Outcomes in Patients Managed by Physicians, Nurse Practitioners, or Physician Assistants: A Cohort StudyGeorge L Jackson, Valerie A Smith, David Edelman, et al.
Experimental Hematology|June 1, 1989
Tissue iron deposition in untransfused beta-thalassemic miceL M Garrick, L A Strano-Paul, J E Hoke, et al.
Family Medicine|October 15, 2016
Dr Carek's Commentary on Training PAs and NPsChristine M Everett, Viviana Martinez-Bianchi, Perri Morgan, et al.
American Heart Journal|September 23, 2022
Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical careRishi J Desai, Robert J Glynn, Brendan M Everett, et al.
Diabetes Care|March 4, 2026
Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial EmulationsJohn W Ostrominski, Janinne Ortega-Montiel, Deborah J Wexler, et al.
Pageof 37